BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 0.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 975,612 shares of the technology company's stock after purchasing an additional 6,257 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 3.60% of Plexus worth $125,005,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Aquatic Capital Management LLC raised its holdings in Plexus by 134.0% during the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after acquiring an additional 134 shares during the period. Versant Capital Management Inc grew its position in Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock worth $61,000 after acquiring an additional 430 shares in the last quarter. TD Private Client Wealth LLC boosted its position in Plexus by 185.6% during the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock valued at $66,000 after buying an additional 334 shares during the period. N.E.W. Advisory Services LLC purchased a new stake in Plexus during the first quarter valued at about $87,000. Finally, Blue Trust Inc. boosted its holdings in shares of Plexus by 49.2% during the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock worth $108,000 after purchasing an additional 279 shares during the period. Institutional investors own 94.45% of the company's stock.
Plexus Price Performance
PLXS stock traded up $6.71 during mid-day trading on Friday, hitting $137.26. The company had a trading volume of 151,618 shares, compared to its average volume of 180,705. The company has a market capitalization of $3.70 billion, a price-to-earnings ratio of 23.38 and a beta of 0.80. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average price of $132.44 and a 200 day moving average price of $130.15.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the firm posted $1.45 EPS. The business's quarterly revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.
Insider Buying and Selling
In related news, CFO Patrick John Jermain sold 2,178 shares of the stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $130.42, for a total value of $284,054.76. Following the sale, the chief financial officer directly owned 23,459 shares of the company's stock, valued at $3,059,522.78. This represents a 8.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Karen Marie Rapp sold 500 shares of the stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $130.77, for a total transaction of $65,385.00. Following the completion of the sale, the director directly owned 9,365 shares in the company, valued at $1,224,661.05. This trade represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 12,484 shares of company stock worth $1,626,335 over the last three months. 1.76% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
PLXS has been the subject of a number of analyst reports. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and increased their target price for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Needham & Company LLC decreased their target price on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research note on Thursday, July 24th. Stifel Nicolaus set a $140.00 price target on shares of Plexus in a research report on Thursday, July 24th. Benchmark reissued a "buy" rating and set a $160.00 price target on shares of Plexus in a research report on Wednesday, June 4th. Finally, Wall Street Zen downgraded shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Plexus currently has an average rating of "Moderate Buy" and an average price target of $152.00.
Read Our Latest Stock Analysis on Plexus
About Plexus
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.